01/04/2026
H-Ventures Group joined the discussion:
“The Future of Supply Chain: Opportunities, Challenges and New Perspectives”,
organized by IQVIA Italia with the support of LIPHE - Logistica Integrata Pharma Healthcare
A key takeaway clearly emerged from this high-level exchange:
The evolution toward a true ecosystem, where integration is no longer only operational and technological, but increasingly institutional and political.
As highlighted by Antonella Levante (CEO, IQVIA Italia & Greece):
The direction is clear. We are moving together toward an Orchestrated Supply Chain: seamless integration across the supply chain, powered by digital transformation, enabling real-time data sharing, end-to-end visibility, and agility.
As emphasized by LIPHE | Logistica Integrata Pharma Healthcare President Pierluigi Petrone:
The shift from linear to collaborative models, now extended to include public institutions and regulatory stakeholders, is no longer optional. It requires a new level of coordination, shared responsibility, and alignment across the entire system. Success cannot be achieved alone: only through a truly integrated, multi-stakeholder approach can we ensure resilience, efficiency, and continuity of care.
Adding a global perspective, Alfredo Sassi, CEO of H-Ventures Group and VP of LIPHE | Logistica Integrata Pharma Healthcare:
“Following today’s discussion, we must take a decisive step forward, not only in how we operate, but in how we think and speak about our industry. It is time to move beyond the concept of ‘pharma supply chain’ and adopt a new paradigm: the ‘pharma logistics ecosystem.’ This is not just a semantic shift!! A supply chain is linear and transactional; an ecosystem is interconnected, dynamic, and real-time, where data, technologies, stakeholders, and institutions co-create value and resilience, with the patient at the center. This also requires strong transatlantic alliances between Europe and the United States, especially to enable the scalable deployment of innovative therapies.”
